ZA933221B - Agent and process for treating body fluids in the determination of neopterin - Google Patents

Agent and process for treating body fluids in the determination of neopterin

Info

Publication number
ZA933221B
ZA933221B ZA933221A ZA933221A ZA933221B ZA 933221 B ZA933221 B ZA 933221B ZA 933221 A ZA933221 A ZA 933221A ZA 933221 A ZA933221 A ZA 933221A ZA 933221 B ZA933221 B ZA 933221B
Authority
ZA
South Africa
Prior art keywords
neopterin
determination
agent
body fluids
treating body
Prior art date
Application number
ZA933221A
Other languages
English (en)
Inventor
Wilfried Rautenberg
Arnulf Heubner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA933221B publication Critical patent/ZA933221B/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA933221A 1992-05-09 1993-05-07 Agent and process for treating body fluids in the determination of neopterin ZA933221B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4215275A DE4215275A1 (de) 1992-05-09 1992-05-09 Mittel und Verfahren zur Behandlung von Körperflüssigkeiten bei der Bestimmung von Neopterin

Publications (1)

Publication Number Publication Date
ZA933221B true ZA933221B (en) 1993-12-08

Family

ID=6458470

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933221A ZA933221B (en) 1992-05-09 1993-05-07 Agent and process for treating body fluids in the determination of neopterin

Country Status (8)

Country Link
US (1) US5439799A (xx)
EP (1) EP0569768A1 (xx)
JP (1) JPH0643160A (xx)
CA (1) CA2095780A1 (xx)
CZ (1) CZ83393A3 (xx)
DE (1) DE4215275A1 (xx)
IL (1) IL105629A (xx)
ZA (1) ZA933221B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE506533C2 (sv) * 1995-07-03 1998-01-12 Birger Andersson En process för in vitro analys av substansers toxiska och allergena egenskaper samt användning av neopterin för att skilja mellan allergiska immunreaktioner
USRE38423E1 (en) 1995-07-03 2004-02-10 Biovator Technologies Ab Process for in vitro analysis of toxic and allergenic substances
GB0130947D0 (en) * 2001-12-24 2002-02-13 Lee Helen Improved sample preparation for the detection of infectious agents
EP3977999A1 (en) * 2003-11-17 2022-04-06 BioMarin Pharmaceutical Inc. Treatment of phenylketonuria with bh4
AU2005306686B2 (en) * 2004-11-17 2011-06-02 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
EP2438447B1 (en) * 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967143D1 (en) * 1978-12-18 1984-08-30 Wachter Helmut Diagnostic method, especially for the early recognition of malignant tumors and/or viral diseases, and means to carry it out
GB2056459B (en) * 1979-07-04 1983-03-09 Daiichi Radioisotope Lab Pterin derivatives and an assay method for determining pterins
JPS57208459A (en) * 1981-06-19 1982-12-21 Eisai Co Ltd Measuring method using enzyme-labelled antibody and reagent
DE3211167A1 (de) * 1982-03-26 1983-09-29 Merck Patent Gmbh, 6100 Darmstadt Testsystem und verfahren zur bestimmung von substanzen in fluessigkeiten
US4668620A (en) * 1984-02-22 1987-05-26 Syntex (U.S.A.) Inc. Reducing background interference activity in enzyme-label immunoassays
DE3725475A1 (de) * 1987-07-31 1989-02-09 Boehringer Mannheim Gmbh Verfahren zur beseitigung von unspezifischen truebungen
DE68925387T2 (de) * 1988-06-22 1996-08-14 Hygeia Sciences Ltd Verfahren zur Behandlung von Immunotest-Proben, die Schleim enthalten
US4978632A (en) * 1988-12-15 1990-12-18 Kallestad Diagnostics, Inc. Method of pre-treating samples in peroxidase-catalyzed enzyme assays

Also Published As

Publication number Publication date
CZ83393A3 (en) 1993-11-17
US5439799A (en) 1995-08-08
JPH0643160A (ja) 1994-02-18
EP0569768A1 (de) 1993-11-18
DE4215275A1 (de) 1993-11-11
IL105629A0 (en) 1993-09-22
IL105629A (en) 1996-10-31
CA2095780A1 (en) 1993-11-10

Similar Documents

Publication Publication Date Title
US5499995C1 (en) Body passageway closure apparatus and method of use
GB9401176D0 (en) Device for preventing or reducing the incidence or intensity of pain in the body
GB2277480B (en) Topsheet of body fluid absorptive articles and method for making same
ZA943119B (en) Surface treating articles and methods of making same
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
SG48279A1 (en) Method and apparatus for the surface treatment of parts
ZA933221B (en) Agent and process for treating body fluids in the determination of neopterin
AP9300555A0 (en) Therapeutic agent and its use
IL92777A0 (en) Method and agent for the determination of maleimide groups
GB2260984B (en) Agent and method for treating the surfaces of metals
GB9317864D0 (en) Processing of proteincontaining body fluids
EP0618233A3 (de) Verfahren zur Herstellung und Aufarbeitung von in wässrigem Medium löslichen N-Hydroxyalkylchitosanen.
GB2261832B (en) Method of treating waste and apparatus for use in the method
GB8903820D0 (en) Compositions for simple detection and/or quantification of anti-genic substances in body liquids
GB2278348B (en) Method of reducing contamination and composition for use in the method
GB9010058D0 (en) Method and composition for the treatment of cancer
EP0449291A3 (en) Process for the creation of selective fluorescent sites or regions in parylene films and coatings
PL288990A1 (en) Finely grained agent and method of and apparatus for chemical and/or physical treatment of fluids
PL306093A1 (en) Cataract treating agent and method of obtaining same
EP0693544A3 (en) Process for the treatment and recovery of crude oils
EP0893123A4 (en) MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM
EP0553611A3 (en) Process and container for the treatment of must
ZA89589B (en) Tanning agent and process
ZA952067B (en) Baths and process for the chemical polishing of stainless steel surfaces
ZA945567B (en) Water treatment agent and method of its use